» Authors » Dan Rusinaru

Dan Rusinaru

Explore the profile of Dan Rusinaru including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 115
Citations 1752
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Scheggi V, Bohbot Y, Hasan J, Vanhaecke P, Del Pace S, Fumagalli C, et al.
Infez Med . 2025 Mar; 33(1):98-105. PMID: 40071261
Background: Fever following transcatheter aortic valve implantation (TAVI) poses a clinical challenge, necessitating a comprehensive diagnostic approach to discern between infectious and non-infectious origins. Despite its minimally invasive nature, TAVI...
2.
Bohbot Y, Essayagh B, Benfari G, Bax J, Le Tourneau T, Topilsky Y, et al.
J Am Heart Assoc . 2024 Dec; 14(1):e036206. PMID: 39692024
Background: The prevalence and impact of right ventricular dysfunction (RVD) in degenerative mitral regurgitation (DMR) is unknown. We aimed to determine whether RVD assessed by echocardiography in routine clinical practice...
3.
Hamid N, Bursi F, Benfari G, Vanoverschelde J, Tribouilloy C, Biagini E, et al.
JACC Asia . 2024 Aug; 4(6):468-480. PMID: 39100700
Background: Clinical outcome and interventional thresholds for degenerative mitral regurgitation (DMR) were developed in studies of patients at European and American institutions (EAIs), but little is known about patients at...
4.
Tribouilloy C, Rusinaru D, Grigioni F, Avierinos J, Vanoverschelde J, Benfari G, et al.
Eur J Heart Fail . 2024 Jul; 26(12):2563-2569. PMID: 39036937
Aims: In patients with degenerative mitral regurgitation (DMR), left ventricular (LV) dysfunction is associated with increased risk of heart failure and excess mortality. LV end-systolic diameter (LVESD) is an established...
5.
Trojette F, Di Lena C, Bohbot Y, Rusinaru D, Tribouilloy C
Rev Prat . 2024 Jul; 74(6):653-659. PMID: 39011700
COMPLICATIONS OF INFECTIVE ENDOCARDITIS. The high in-hospital mortality of patients with infective endocarditis (about 20%) is mainly due to its complications. These complications are essentially of cardiac, neurological, and infectious...
6.
Vancraeynest D, Pouleur A, de Meester C, Pasquet A, Gerber B, Michelena H, et al.
Eur Heart J Cardiovasc Imaging . 2024 Jul; 25(12):1703-1711. PMID: 38996050
Aims: Operating on patients with severe degenerative mitral regurgitation (DMR) is based on ACC/AHA or ESC/EACTS guidelines. Doubts persist on best surgical indications and their potential association with postoperative survival...
7.
De Azevedo D, Boute M, Tribouilloy C, Marechaux S, Pouleur A, Bohbot Y, et al.
JACC Adv . 2024 Jun; 3(3):100830. PMID: 38938822
Background: International guidelines recommend aortic valve replacement (AVR) as Class I triggers in high-gradient severe aortic stenosis (HGSAS) patients with symptoms and/or left ventricular ejection fraction (LVEF) <50%. The association...
8.
De Azevedo D, Tribouilloy C, Marechaux S, Pouleur A, Bohbot Y, Rusinaru D, et al.
JACC Adv . 2024 Jun; 2(2):100254. PMID: 38938309
Background: Up to 30% of patients with severe aortic stenosis (SAS) (indexed aortic valve area [AVAi] <0.6 cm/m) exhibit low-transvalvular gradient despite normal ejection fraction. There is intense debate regarding...
9.
Essayagh B, Benfari G, Antoine C, Grigioni F, Le Tourneau T, Roussel J, et al.
JACC Cardiovasc Imaging . 2024 Jun; 17(10):1149-1163. PMID: 38934979
Background: European and U.S. clinical guidelines diverge regarding pulmonary hypertension (PHTN) in degenerative mitral regurgitation (DMR). Gaps in knowledge underpinning these divergences affect risk assessment and management recommendations attached to...
10.
Avierinos J, Tribouilloy C, Bursi F, Grigioni F, Vanoverschelde J, Resseguier N, et al.
Eur Heart J . 2024 May; 45(26):2306-2316. PMID: 38751052
Background And Aims: Presentation, outcome, and management of females with degenerative mitral regurgitation (DMR) are undefined. We analysed sex-specific baseline clinical and echocardiographic characteristics at referral for DMR due to...